Area of research
Pharmacy · Surgery
Research interest
Research interests include Medicine, Obesity, Overweight, Internal medicine, Weight loss, and Body mass index.
Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1
International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the <scp>STEP</scp> 1–4 trials
IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management—an International Delphi Study
Le maintien de sémaglutide (2,4 mg/semaine) a permis une amélioration de la qualité de vie liée à la santé
Obesity in adults: a clinical practice guideline
Time for a new obesity narrative
Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
Weight bias reduction in health professionals: a systematic review
Secular differences in the association between caloric intake, macronutrient intake, and physical activity with obesity
Edmonton Obesity Staging System Prevalence and Association with Weight Loss in a Publicly Funded Referral-Based Obesity Clinic
Response to ‘Energy balance measurement: when something is not better than nothing’
Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling
Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease
Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial
Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals
Influence of a clinical lifestyle‐based weight loss program on the metabolic risk profile of metabolically normal and abnormal obese adults
Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes
Difference in weight loss based on ethnicity, age and comorbidity status in a publicly funded adult weight management centre: 1‐year results
Edmonton Obesity Staging System Prevalence in the Wharton Medical Clinic and the Association with Weight Loss
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes
Single-Pill Combination of Telmisartan/Amlodipine Versus Amlodipine Monotherapy in Diabetic Hypertensive Patients: An 8-Week Randomized, Parallel-Group, Double-Blind Trial